MediWound MDWD 深 沪
等待开盘 08-21 09:30:00 美东时间
13.16
-0.430
-3.16%
华盛通- 最 高13.60
- 今 开13.60
- 成交量 5.53万股
- 最 低 13.07
- 昨 收 13.59
- 总市值 1.70亿
- 52周最高 20.30
- 市盈率 静 --
- 换手率 0.43%
- 52周最低 13.07
- 委 比 24.58%
- 总股本 1291.03万
- 历史最高 135.17
- 量 比 1.17
- 振 幅 3.90%
- 历史最低 7.10
- 每 手 1
- 风险率 1.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30
Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $32 to $30.
08-15 01:10
MediWound (MDWD) 2026年第二季度业绩电话会：VALU按计划推进，重申业绩指引
MediWound 2026年第二季度营收降至310万美元，随着VALU试验入组按计划推进，管理层重申了2400万至2600万美元的业绩指引。
08-14 08:28
MediWound Q2 EPS $(0.77) Misses $(0.76) Estimate, Sales $3.092M Beat $2.588M Estimate
MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.76) by 1.32 percent. This is a 37.4 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $3.092 million which...
08-13 19:02
MediWound to Report Second Quarter 2026 Financial Results
MediWound Ltd. (Nasdaq: MDWD), a global leader in enzymatic therapeutics for tissue repair, announced it will release its second quarter 2026 financial results on August 13, 2026. A conference call and webcast will be held at 8:30 a.m. Eastern Time on the same day to discuss the results and provide a corporate update. The company's FDA-approved product, NexoBrid®, is used for enzymatic removal of eschar in thermal burns, and its pipeline product,...
07-29 12:00
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32
Oppenheimer analyst Francois Brisebois maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $33 to $32.
05-28 23:07
MediWound shares are trading lower after the company reported mixed Q1 financial results.
MediWound shares are trading lower after the company reported mixed Q1 financia...
05-28 02:19
MediWound Reports Q1 2026 Results: Full Earnings Call Transcript
MediWound (NASDAQ:MDWD) reported first-quarter financial results on Wednesday. ...
05-27 21:33
MediWound Affirms FY2026 Sales Guidance of $24.000M-$26.000M vs $24.759M Est
MediWound (NASDAQ:MDWD) affirms FY2026 sales outlook from $24.000 million-$26.000 million to $24.000 million-$26.000 million vs $24.759 million estimate.
05-27 19:02
